ImStem Biotechnology
Business Services · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Farmington Ave, Farmington, Connecti...Phone Number
(860) 281-7836Website
www.imstem.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ImStem Biotechnology
ImStem Biotechnology is an innovative biopharmaceutical company that focuses on pioneering stem cell technology to develop transformative medicines for patients with autoimmune, degenerative, and rare diseases. Their proprietary T-MSC technology differentiates human embryonic stem cells into mesenchymal stem cells, which are currently being studied in clinical trials for multiple sclerosis. The company aims to improve treatment outcomes and quality of life for patients through their advanced research and development efforts. Founded in 2012, ImStem is committed to translating scientific research into effective therapies.Explore more
ImStem Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ImStem Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on ImStem Biotechnology recently announced quarterly report
Funding: Get notified immidiatlly once ImStem Biotechnology has new funding data
Check if ImStem Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Click to see if ImStem Biotechnology had a recent Job posting/layoffs
Product Launch: Get notified when ImStem Biotechnology launches new products
Check out if ImStem Biotechnology is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ImStem Biotechnology
ImStem Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined ImStem Biotechnology as Masked Content
Find more new buyers
Compare Similar Companies to ImStem Biotechnology
Compare insights from companies similar to ImStem Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ImStem Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ImStem Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ImStem Biotechnology.
ImStem Biotechnology financials insights
Gather financial insights about ImStem Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$143K
ImStem Biotechnology Tech Stack
A closer look at the technologies used by ImStem Biotechnology
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Pain Point
Pain Point, Bankruptcy
New Hire
Executive Move
New Hire
Executive Move
ImStem Biotechnology has announced that Ernst Zwikker has joined the organization as Chief Financial Officer. Previously, Zwikker served as Vice President & Corporate Controller for PureTech Health.
Funding
ImStem Biotechnology News & Media
ImStem Biotechnology Appoints CNS and Rare Disease Veteran Rami Levin as its Chief Executive Officer
ImStem Appoints new CEO FARMINGTON, CT, USA, September 2, 2022 /EINPresswire.com/ -- ImStem Biotechnology, a clinical stage biotechnology company focused on stem cell based regenerative cellular therapies to treat serious diseases with high unmet needs, …Prof. Rudolf Jaenisch joins ImStem Biotechnology as Member of its Scientific Advisory Board
FARMINGTON, CT, USA, August 29, 2022 /EINPresswire.com/ -- ImStem Biotechnology, Inc., a clinical stage biotechnology company focused on human pluripotent stem cell based regenerative cellular therapies to treat serious diseases with high unmet need, …ImStem appeals to the Federal Circuit a judgement concerning inventorship of claims in certain stem cell patents
ImStem appeals to the U.S. Court of Appeals for the Federal Circuit a lower court’s judgment concerning inventorship of claims in certain stem cell patents FARMINGTON, CT, UNITED STATES, April 11, 2022 /EINPresswire.com/ -- ImStem Biotechnology, Inc. (“ …AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001
ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced today that ImStem Biotechnology, Inc. (“ImStem”), a biopharmaceutical company developing human embryonic stem cell (ESC)-derived mesenchymal stem cells, has dosed the first U.S. multiple sclerosis (MS) patient with ImStem’s lead investigational drug candidate IMS001 at the Shepherd Center in Atlanta, GA. IM
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding ImStem Biotechnology
Sign Up For FreeTo access detailed company insights
ImStem Biotechnology is an innovative biopharmaceutical company that focuses on pioneering stem cell technology to develop transformative medicines for patients with autoimmune, degenerative, and rare diseases. Their proprietary T-MSC technology differentiates human embryonic stem cells into mesenchymal stem cells, which are currently being studied... Read More
